Clinical trial
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive…
NCT00281216 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00281216 |
|---|---|
| Title | Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations |
| Official title | Innate and Adaptive Immunity in COPD Exacerbations: Prospective Cohort Study |
| Lead sponsor | University of Michigan, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive |
| Enrollment | 10 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Jan 24, 2006 |
| Last update posted | Jan 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: